255,061 research outputs found
Retrosynthetic reaction prediction using neural sequence-to-sequence models
We describe a fully data driven model that learns to perform a retrosynthetic
reaction prediction task, which is treated as a sequence-to-sequence mapping
problem. The end-to-end trained model has an encoder-decoder architecture that
consists of two recurrent neural networks, which has previously shown great
success in solving other sequence-to-sequence prediction tasks such as machine
translation. The model is trained on 50,000 experimental reaction examples from
the United States patent literature, which span 10 broad reaction types that
are commonly used by medicinal chemists. We find that our model performs
comparably with a rule-based expert system baseline model, and also overcomes
certain limitations associated with rule-based expert systems and with any
machine learning approach that contains a rule-based expert system component.
Our model provides an important first step towards solving the challenging
problem of computational retrosynthetic analysis
In silico generation of novel, drug-like chemical matter using the LSTM neural network
The exploration of novel chemical spaces is one of the most important tasks
of cheminformatics when supporting the drug discovery process. Properly
designed and trained deep neural networks can provide a viable alternative to
brute-force de novo approaches or various other machine-learning techniques for
generating novel drug-like molecules. In this article we present a method to
generate molecules using a long short-term memory (LSTM) neural network and
provide an analysis of the results, including a virtual screening test. Using
the network one million drug-like molecules were generated in 2 hours. The
molecules are novel, diverse (contain numerous novel chemotypes), have good
physicochemical properties and have good synthetic accessibility, even though
these qualities were not specific constraints. Although novel, their structural
features and functional groups remain closely within the drug-like space
defined by the bioactive molecules from ChEMBL. Virtual screening using the
profile QSAR approach confirms that the potential of these novel molecules to
show bioactivity is comparable to the ChEMBL set from which they were derived.
The molecule generator written in Python used in this study is available on
request.Comment: in this version fixed some reference number
An agent-based fuzzy cognitive map approach to the strategic marketing planning for industrial firms
This is the post-print version of the final paper published in Industrial Marketing Management. The published article is available from the link below. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. Copyright @ 2013 Elsevier B.V.Industrial marketing planning is a typical example of an unstructured decision making problem due to the large number of variables to consider and the uncertainty imposed on those variables. Although abundant studies identified barriers and facilitators of effective industrial marketing planning in practice, the literature still lacks practical tools and methods that marketing managers can use for the task. This paper applies fuzzy cognitive maps (FCM) to industrial marketing planning. In particular, agent based inference method is proposed to overcome dynamic relationships, time lags, and reusability issues of FCM evaluation. MACOM simulator also is developed to help marketing managers conduct what-if scenarios to see the impacts of possible changes on the variables defined in an FCM that represents industrial marketing planning problem. The simulator is applied to an industrial marketing planning problem for a global software service company in South Korea. This study has practical implication as it supports marketing managers for industrial marketing planning that has large number of variables and their cause–effect relationships. It also contributes to FCM theory by providing an agent based method for the inference of FCM. Finally, MACOM also provides academics in the industrial marketing management discipline with a tool for developing and pre-verifying a conceptual model based on qualitative knowledge of marketing practitioners.Ministry of Education, Science and Technology (Korea
The benefits of in silico modeling to identify possible small-molecule drugs and their off-target interactions
Accepted for publication in a future issue of Future Medicinal Chemistry.The research into the use of small molecules as drugs continues to be a key driver in the development of molecular databases, computer-aided drug design software and collaborative platforms. The evolution of computational approaches is driven by the essential criteria that a drug molecule has to fulfill, from the affinity to targets to minimal side effects while having adequate absorption, distribution, metabolism, and excretion (ADME) properties. A combination of ligand- and structure-based drug development approaches is already used to obtain consensus predictions of small molecule activities and their off-target interactions. Further integration of these methods into easy-to-use workflows informed by systems biology could realize the full potential of available data in the drug discovery and reduce the attrition of drug candidates.Peer reviewe
- …